Literature DB >> 22274909

Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton's jelly.

Parvin Salehinejad1, Noorjahan Banu Alitheen, Abdul Manaf Ali, Abdul Rahman Omar, Maryam Mohit, Ehsan Janzamin, Fazel Sahraneshin Samani, Zahra Torshizi, Seyed Noureddin Nematollahi-Mahani.   

Abstract

Several techniques have been devised for the dissociation of tissues for primary culture. These techniques can affect the quantity and quality of the isolated cells. The aim of our study was to develop the most appropriate method for the isolation of human umbilical cord-derived mesenchymal (hUCM) cells. In the present study, we compared four methods for the isolation of hUCM cells: three enzymatic methods; collagenase/hyaluronidase/trypsin (CHT), collagenase/trypsin (CT) and trypsin (Trp), and an explant culture (Exp) method. The trypan blue dye exclusion test, the water-soluble tetrazolium salt-1 (WST-1) assay, flow cytometry, alkaline phosphatase activity and histochemical staining were used to evaluate the results of the different methods. The hUCM cells were successfully isolated by all methods but the isolation method used profoundly altered the cell number and proliferation capacity of the isolated cells. The cells were successfully differentiated into adipogenic and osteogenic lineages and alkaline phosphatase activity was detected in the hUCM cell colonies of all groups. Flow cytometry analysis revealed that CD44, CD73, CD90 and CD105 were expressed in all groups, while CD34 and CD45 were not expressed. The expression of C-kit in the enzymatic groups was higher than in the explant group, while the expression of Oct-4 was higher in the CT group compared to the other groups. We concluded that the collagenase/trypsin method of cell isolation yields a higher cell density than the others. These cells expressed a higher rate of pluripotent cell markers such as C-kit and Oct-4, while the explant method of cell isolation resulted in a higher cell proliferation rate and activity compared to the other methods.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22274909     DOI: 10.1007/s11626-011-9480-x

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  38 in total

Review 1.  Stem cells and aging: expanding the possibilities.

Authors:  M S Rao; M P Mattson
Journal:  Mech Ageing Dev       Date:  2001-05-31       Impact factor: 5.432

2.  Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord.

Authors:  Hwai-Shi Wang; Shih-Chieh Hung; Shu-Tine Peng; Chun-Chieh Huang; Hung-Mu Wei; Yi-Jhih Guo; Yu-Show Fu; Mei-Chun Lai; Chin-Chang Chen
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

Review 3.  Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.

Authors:  Donald G Phinney; Darwin J Prockop
Journal:  Stem Cells       Date:  2007-09-27       Impact factor: 6.277

Review 4.  Promising new sources for pluripotent stem cells.

Authors:  Christian Leeb; Marcin Jurga; Colin McGuckin; Richard Moriggl; Lukas Kenner
Journal:  Stem Cell Rev Rep       Date:  2010-03       Impact factor: 5.739

Review 5.  Mesenchymal stem cells: characteristics and clinical applications.

Authors:  Sylwia Bobis; Danuta Jarocha; Marcin Majka
Journal:  Folia Histochem Cytobiol       Date:  2006       Impact factor: 1.698

6.  Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease.

Authors:  Mark L Weiss; Satish Medicetty; Amber R Bledsoe; Raja Shekar Rachakatla; Michael Choi; Shosh Merchav; Yongquan Luo; Mahendra S Rao; Gopalrao Velagaleti; Deryl Troyer
Journal:  Stem Cells       Date:  2005-10-13       Impact factor: 6.277

7.  Potential of human umbilical cord matrix and rabbit bone marrow-derived mesenchymal stem cells in repair of surgically incised rabbit external anal sphincter.

Authors:  Mahmoud Aghaee-Afshar; Mohammad Rezazadehkermani; Alireza Asadi; Reza Malekpour-Afshar; Armita Shahesmaeili; Seyed Noureddin Nematollahi-mahani
Journal:  Dis Colon Rectum       Date:  2009-10       Impact factor: 4.585

8.  Comparison of mesenchymal stem cells from human placenta and bone marrow.

Authors:  Yi Zhang; Chang-dong Li; Xiao-xia Jiang; He-lian Li; Pei-hsien Tang; Ning Mao
Journal:  Chin Med J (Engl)       Date:  2004-06       Impact factor: 2.628

9.  Human mesenchymal stem cells isolated from the umbilical cord.

Authors:  Chun Qiao; Wenrong Xu; Wei Zhu; Jiabo Hu; Hui Qian; Qing Yin; Runqiu Jiang; Yongmin Yan; Fei Mao; Huan Yang; Xingzhong Wang; Yongchang Chen
Journal:  Cell Biol Int       Date:  2007-08-19       Impact factor: 3.612

10.  Preferential loss of abnormal prostate carcinoma cells by collagenase treatment.

Authors:  J J König; J W van Dongen; F H Schröder
Journal:  Cytometry       Date:  1993-10
View more
  50 in total

1.  In vitro evaluation of the effects of human umbilical cord extracts on human fibroblasts, keratinocytes, and melanocytes.

Authors:  Phuc Van Pham; Loan Thi-Tung Dang; Uyen Thanh Dinh; Huyen Thi-Thu Truong; Ba Ngoc Huynh; Dong Van Le; Ngoc Kim Phan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-10-26       Impact factor: 2.416

2.  In vitro induction and differentiation of umbilical cord mesenchymal stem cells into neuron-like cells by all-trans retinoic acid.

Authors:  Wei Jin; Yao-Peng Xu; An-Huai Yang; Yi-Qiao Xing
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

Review 3.  Therapeutic potential of mesenchymal stem cells for diabetes.

Authors:  Alvaro Moreira; Samuel Kahlenberg; Peter Hornsby
Journal:  J Mol Endocrinol       Date:  2017-07-24       Impact factor: 5.098

4.  Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review.

Authors:  Ioannis Christodoulou; Maria Goulielmaki; Marina Devetzi; Mihalis Panagiotidis; Georgios Koliakos; Vassilis Zoumpourlis
Journal:  Stem Cell Res Ther       Date:  2018-12-07       Impact factor: 6.832

Review 5.  Explant culture: An advantageous method for isolation of mesenchymal stem cells from human tissues.

Authors:  Fatemeh Hendijani
Journal:  Cell Prolif       Date:  2017-02-01       Impact factor: 6.831

6.  Isolation, expansion and characterisation of mesenchymal stem cells from human bone marrow, adipose tissue, umbilical cord blood and matrix: a comparative study.

Authors:  R Secunda; Rosy Vennila; A M Mohanashankar; M Rajasundari; S Jeswanth; R Surendran
Journal:  Cytotechnology       Date:  2014-05-06       Impact factor: 2.058

Review 7.  Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility.

Authors:  Tokiko Nagamura-Inoue; Haiping He
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

8.  A practical way to prepare primer human chondrocyte culture.

Authors:  Mehmet Isyar; Ibrahim Yilmaz; Duygu Yasar Sirin; Sercan Yalcin; Olcay Guler; Mahir Mahirogullari
Journal:  J Orthop       Date:  2016-04-01

Review 9.  Advances in translational orthopaedic research with species-specific multipotent mesenchymal stromal cells derived from the umbilical cord.

Authors:  Melina Ramallo; Irene Carreras-Sánchez; Alba López-Fernández; Roberto Vélez; Màrius Aguirre; Sara Feldman; Joaquim Vives
Journal:  Histol Histopathol       Date:  2020-09-11       Impact factor: 2.303

10.  Effect of EGF and FGF on the expansion properties of human umbilical cord mesenchymal cells.

Authors:  Parvin Salehinejad; Noorjahan Banu Alitheen; Ali Mandegary; Seyed Noureddin Nematollahi-Mahani; Ehsan Janzamin
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-05-25       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.